Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Sartorius AG    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
03/01/2021 03/02/2021 03/03/2021 03/04/2021 03/05/2021 Date
395(c) 389(c) 375(c) 363(c) 350(c) Last
1 799 2 912 2 572 4 067 4 835 Volume
+0.51% -1.52% -3.60% -3.20% -3.58% Change
More quotes
Financials
Sales 2021 2 878 M 3 433 M 3 433 M
Net income 2021 353 M 421 M 421 M
Net Debt 2021 1 814 M 2 163 M 2 163 M
P/E ratio 2021 74,9x
Yield 2021 0,32%
Sales 2022 3 241 M 3 865 M 3 865 M
Net income 2022 420 M 501 M 501 M
Net Debt 2022 1 778 M 2 120 M 2 120 M
P/E ratio 2022 65,6x
Yield 2022 0,36%
Capitalization 25 587 M 30 482 M 30 515 M
EV / Sales 2021 9,52x
EV / Sales 2022 8,44x
Nbr of Employees 10 637
Free-Float 46,8%
More Financials
Company
Sartorius AG specializes in the design, manufacturing and marketing of medical equipments for the pharmaceutical, chemical and food processing industries. The group also develops mechatronic instruments for industrial and laboratory applications. Net sales break down by family of products as follows: - biotechnological equipments (75.1%): fermentation, filtration, process, membrane chromatography and fluids storage... 
More about the company
Notations Surperformance© of Sartorius AG
Trading Rating : Investor Rating :
More Ratings
All news about SARTORIUS AG
03/06SARTORIUS  : is a corporate partner of the Healthcare...
PU
02/18SARTORIUS  : Conference Call FY|2020 Presentation
PU
02/18SARTORIUS STEDIM BIOTECH SA  : Communiqué de mise à disposition de documents
DJ
02/15DGAP-AFR  : Sartorius AG: Preliminary announcement of the publication of financi..
DJ
02/15SARTORIUS AG : Preliminary announcement of the publication of financial reports ..
EQ
02/11SARTORIUS  : Resolutions of the Supervisory Board of Sartorius AG
PU
02/10SARTORIUS VORZUEGE  : DZ Bank gives a Sell rating
MD
02/09SARTORIUS  : SIMCA® 17 Now Available with Improved Spectroscopy Modeling for PAT
PU
02/05SARTORIUS  : Polytec jumpstarts collaboration with Sartorius Data Analytics AB
PU
02/04SARTORIUS VORZUEGE  : UBS reiterates its Sell rating
MD
02/03SARTORIUS STEDIM BIOTECH SA  : Declaration relative to the number of shares and ..
DJ
02/01SARTORIUS VORZUEGE  : Raised to Buy by Deutsche Bank
MD
01/29SARTORIUS VORZUEGE  : NorldLB gives a Neutral rating
MD
01/29SARTORIUS VORZUEGE  : Berenberg remains Neutral
MD
01/29SARTORIUS VORZUEGE  : Receives a Buy rating from JP Morgan
MD
More news
News in other languages on SARTORIUS AG
03/06SARTORIUS  : ist Partner der Healthcare Businesswomen's Association
03/04BLICKPUNKT/10 DAX-Aufsteiger für September - Porsche dabei
03/04BLICKPUNKT/DAX ist und bleibt Index der analogen Wirtschaft
03/03DGAP-HV : TUI AG: Bekanntmachung der Einberufung -27-
03/03Aktien Frankfurt Schluss: Dax auf Achterbahnfahrt nach Rekordhoch
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Average target price 331,25 €
Last Close Price 350,00 €
Spread / Highest target 48,6%
Spread / Average Target -5,36%
Spread / Lowest Target -80,4%
EPS Revisions
Managers and Directors
NameTitle
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS AG1.45%30 482
REVENIO GROUP OYJ3.18%1 605
VAREX IMAGING CORPORATION36.87%911
CELLAVISION AB (PUBL)-4.36%810
OXFORD IMMUNOTEC GLOBAL PLC25.85%562
CO-DIAGNOSTICS, INC.41.94%349